Fresh Equities
ASX:ADR

ASX:ADR

ADHERIUM LIMITED

4W AVG VOLUME
-
Data provided by Weblink | as of last close
4W AVG TURNOVER
-

ADHERIUM LIMITED has not announced any current capital raises, but we are collecting interest for future raises.

Demand Registered for Next Raise
< $50k
Investors Interested in Next Raise
< 10
How Fresh Equities Works
Authentication

1. Create Account

Complete your onboarding digitally in less than 3 minutes.

Authentication

2. View Terms

View the full term sheet for the capital raise.

Authentication

3. Bid for Allocation

Submit and track your bid online.

Capital Raise History

Loading...


Company Overview

Adherium Limited (ADR) develops, manufactures and supplies digital health technologies which address sub-optimal medication use in chronic disease. Adherium operates globally from bases in New Zealand, Australia, USA and UK.

Type

Listed Company

GICS Sub-industry

Health Care Technology

Head Office

Level 2/204 Quay St, Auckland, 1010, New Zealand

Health Care Technology
Health Care
Biotech & Health

Price Chart


Quarterly Cash Flows

The numbers below are derived from quarterly cash flow reports provided by the company. Fresh Equities does not guarantee that the information provided is accurate, you can read the associated report by clicking read more for the quarter. Always do your own research and do not rely on the information provided here as your only source of research.

Loading...


Directors


Announcements

All
All Time
    Rights Issue results and Shortfall notification on 28 January 2020

    Issued Capital

    Non-renounceable rights issue timetable amendment on 23 January 2020

    Issued Capital

    Non-renounceable rights issue timetable amendment on 15 January 2020

    Issued Capital

    Adherium appoints Jane Lapon as Head of Global Market Access on 8 January 2020

    Company Administration

    CEO Letter to Shareholders on 3 January 2020

    Letter To Shareholders

    Notice to Ineligible Shareholders in Rights Issue Offer on 18 December 2019

    Issued Capital

  • Adherium December 2019 Update Presentation on 18 December 2019

    Periodic Reports

  • Adherium Non-renounceable Rights Issue Offer Document on 18 December 2019

    Issued Capital

  • Notice to Optionholders pursuant to Rights Issue Offer on 11 December 2019

    Issued Capital

    Appendix 3B (pro rata rights issue) on 10 December 2019

    Issued Capital

    Load More

News

Loading...